Double Contrast MR Imaging with Iron Colloid and Gd-DTPA in Cholangiocellular Carcinoma

1994 ◽  
Vol 35 (6) ◽  
pp. 632-633 ◽  
Author(s):  
Y. Suto ◽  
Y. Shimatani ◽  
T. Kato ◽  
M. Kamba ◽  
Y. Ohuchi ◽  
...  

Double contrast MR imaging with combined use of chondroitin sulfate iron colloid (CSIC) and Gd-DTPA was attempted in 3 cases of cholangiocellular carcinoma (CCC). In all cases, nonenhanced spin echo T1- and T2-weighted images, and T1-weighted images after i.v. injection of Gd-DTPA were obtained. Within one week, the MR sequences were repeated one hour after i.v. injection of CSIC. Double contrast (CSIC/Gd-DTPA) T1-weighted imaging was evaluated and compared with the other sequences in terms of tumor detectability, tumor spreading and tumor characterization. Double contrast MR imaging was comparable in tumor detectability and superior as to the evaluation of spreading and characterization to the other MR imaging modalities.

1994 ◽  
Vol 35 (6) ◽  
pp. 632-633
Author(s):  
Y. Suto ◽  
Y. Shimatani ◽  
T. Kato ◽  
M. Kamba ◽  
Y. Ohuchi ◽  
...  

1991 ◽  
Vol 33 (5) ◽  
pp. 422-426 ◽  
Author(s):  
A. Neuhold ◽  
M. Stiskal ◽  
Ch. Platzer ◽  
G. Pernecky ◽  
M. Brainin

1994 ◽  
Vol 35 (6) ◽  
pp. 632-633 ◽  
Author(s):  
Y. Suto ◽  
Y. Shimatani ◽  
T. Kato ◽  
M. Kamba ◽  
Y. Ohuchi ◽  
...  

1994 ◽  
Vol 35 (6) ◽  
pp. 570-575 ◽  
Author(s):  
M. Kamba ◽  
Y. Suto ◽  
T. Kato

Chondroitin sulfate iron colloid (CSIC) was used as an MR contrast agent for the detection of hepatocellular carcinoma (HCC). The findings of 25 surgically confirmed HCCs in 19 patients were retrospectively analyzed. T1-, T2- and proton density-weighted spin echo MR images were obtained before and after i.v. injection of 23.6 μM Fe/kg of CSIC. Unenhanced and CSIC-enhanced MR images and images obtained by CT during arterial portography (CT-AP) were correlated with surgical pathology findings. The sensitivities of CSIC-enhanced and unenhanced MR imaging, and CT-AP were 92%, 80%, and 88%, respectively. No significant differences were noted. Portal flow abnormalities demonstrated by CT-AP did not affect the detection of HCC by CSIC-enhanced MR imaging. CSIC-enhancement at MR imaging was a disadvantage in the detection of lesions less than 1 cm in diameter. CSIC-enhanced MR imaging is a supplemental method for the detection of HCC.


1995 ◽  
Vol 36 (4) ◽  
pp. 346-352 ◽  
Author(s):  
Stefan Nilsson ◽  
Mats Wikstrom ◽  
Anders Ericsson ◽  
Gerhard Wikstrom ◽  
Anders Waldenstrom ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document